Brief: Onxeo Announces That Nasdaq Approved The Delisting Of Its Shares From The First North Growth Market In Copenhagen
Aug 30 (Reuters) - Onxeo SA ALONX.PA :
* ONXEO ANNOUNCES THAT NASDAQ APPROVED THE DELISTING OF ITS SHARES FROM THE FIRST NORTH
GROWTH
MARKET IN COPENHAGEN
Source text for Eikon: ID:nBw8yn1NMa
Further company coverage: ALONX.PA
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Valerio Therapeutics SA
See all newsBrief: Valerio Therapeutics To Buy Etherna Immunotherapies For €30 Mln
Brief: Valerio Therapeutics Signs Development Collaboration With Abivax
Brief: Valerio Therapeutics Enters Into Collaboration & Exclusive License With Seed-Stage Biotech Co
Brief: Onxeo Changes Its Name And Becomes Valerio Therapeutics
Brief: Onxeo H1 Net Loss Widens To EUR 11.5 Mln